The treatment of hepatic encephalopathy (HE) is complex and therapeutic regimens vary
according to the acuity of presentation and the goals of therapy. Most treatments for HE rely …

Background Equitable access to pediatric organ transplantation is critical, although risk
factors negatively impacting pre‐and post‐transplant outcomes remain. No synthesis of the …

Health disparities have been well-described in all stages of the liver transplantation (LT)
process. Using data from psychosocial evaluations and the Stanford Integrated …

Racial and socioeconomic disparities exist in liver transplantation (LT) outcomes among
adults, but little research exists for pediatric LT populations. We examined racial differences …

Racial/ethnic disparities in access to and outcomes of liver transplantation are an important
topic given the increasing diversity in the United States. Most reports on this topic predate …

Background We aimed to examine the association between recipient race/ethnicity and sex,
donor liver quality, and liver transplant graft survival. Methods Adult non–status 1 liver …

End-stage liver disease is a major cause of morbidity and mortality among ethnic minorities.
In the United States, ethnic minorities comprise approximately 30% of all adult liver …

Black race is a risk factor for end‐stage renal disease (ESRD). Racial disparities in the risks
of early and long‐term renal complications after liver transplantation (LT) have not been …

Higher rates of hepatitis C virus (HCV) recurrence and lower response to HCV antiviral
therapy contribute to the lower post‐liver transplantation (LT) survival among African …

Purpose An immune function assay has been proposed as a new strategy to monitor
immunosuppression after organ transplantation. However, there are limited data regarding …